BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2116614)

  • 1. Tissue plasminogen activator and penetrating keratoplasty.
    Heidemann DG; Williams GA; Blumenkranz MS
    Ophthalmic Surg; 1990 May; 21(5):364-5. PubMed ID: 2116614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.
    Koerner F; Boehnke M
    Ger J Ophthalmol; 1992; 1(5):354-60. PubMed ID: 1477641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative intraocular fibrin formation is a potentially disastrous complication of vitrectomy surgery.
    McDonald HR; Schatz H; Johnson RN
    Retina; 1990; 10(4):317-8. PubMed ID: 2128550
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of intraocular fibrin formation with tissue plasminogen activator after vitrectomy].
    Zhao P; Wang W
    Zhonghua Yan Ke Za Zhi; 1995 Jul; 31(4):255-8. PubMed ID: 8745515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
    Schmitz K; Greite JH; Bartenschlager EM
    Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracameral tissue plasminogen activator for treatment of excessive fibrin response after penetrating keratoplasty.
    Snyder RW; Sherman MD; Allinson RW
    Am J Ophthalmol; 1990 Apr; 109(4):483-4. PubMed ID: 2109930
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose intraocular tissue plasminogen activator treatment for traumatic total hyphema, postcataract, and penetrating keratoplasty fibrinous membranes.
    Starck T; Hopp L; Held KS; Marouf LM; Yee RW
    J Cataract Refract Surg; 1995 Mar; 21(2):219-24. PubMed ID: 7791066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vitreous hemorrhage after vitrectomy in diabetic retinopathy and tissue plasminogen activator].
    Asensio Sánchez VM; Pérez Flández FJ; Carlos Bejarano J; Fernández Concellón L
    Arch Soc Esp Oftalmol; 2002 Jan; 77(1):7-12. PubMed ID: 11813114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
    Erol N; Ozer A; Topbas S; Yildirim N; Yurdakul S
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator.
    Williams GA; Lambrou FH; Jaffe GA; Snyder RW; Green GD; Devenyi RG; Abrams GW
    Arch Ophthalmol; 1988 Aug; 106(8):1055-8. PubMed ID: 3135790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical tissue plasminogen activator appears ineffective for the clearance of intraocular fibrin.
    Zwaan J; Latimer WB
    Ophthalmic Surg Lasers; 1998 Jun; 29(6):476-83. PubMed ID: 9640569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator.
    Jaffe GJ; Lewis H; Han DP; Williams GA; Abrams GW
    Am J Ophthalmol; 1989 Aug; 108(2):170-5. PubMed ID: 2502924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of topically administered tissue plasminogen activator for intraocular fibrinolysis in dogs.
    Gerding PA; Hamor RE; Ramsey DT; Vasaune S; Schaeffer DJ
    Am J Vet Res; 1994 Oct; 55(10):1368-70. PubMed ID: 7998691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical observation of wound dehiscence after penetrating keratoplasty].
    Huang T; Chen JQ; Chen LS; Liu ZG
    Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):12-6. PubMed ID: 16638274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of tissue plasminogen activator in the post-operative treatment of fibrinoid uveitis].
    Chiseliţă D; Antohi I; Cionca D; Medvichi R; Cimpoeşu D
    Oftalmologia; 2006; 50(2):68-72. PubMed ID: 16927762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator for postvitrectomy fibrin formation.
    Jaffe GJ; Abrams GW; Williams GA; Han DP
    Ophthalmology; 1990 Feb; 97(2):184-9. PubMed ID: 2109297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative fibrin formation and visual outcome after pars plana vitrectomy.
    Han DP; Wang Q; Hartz A; Jaffe GJ; Murray TG; Boldt HC; Arrindell EL; Coe E; Abrams GW; Mieler WF
    Retina; 1994; 14(3):225-30. PubMed ID: 7973117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe anterior segment inflammation following corneal surgery for keratoconus.
    Shands PR; Lass JH
    Ophthalmic Surg; 1990 Sep; 21(9):645-6. PubMed ID: 2250873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Band-like keratopathy after treatment of postoperative fibrin reaction with tissue plasminogen activator].
    Wollensak G; Meyer JH; Löffler KU; Funk J
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):43-6. PubMed ID: 8965477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracameral fibrin tissue sealant as an adjunct in tectonic lamellar keratoplasty for large corneal perforations.
    Por YM; Tan YL; Mehta JS; Tan DT
    Cornea; 2009 May; 28(4):451-5. PubMed ID: 19411966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.